Lymphocyte count and lymphocyte-to-white blood cells ratio as indicators of survival in specific cancer subtypes
Int Immunopharmacol
.
2019 Dec:77:105982.
doi: 10.1016/j.intimp.2019.105982.
Epub 2019 Oct 31.
Authors
M Cefalì
1
,
A Efstathopoulou
2
,
S De Dosso
2
,
P Saletti
2
Affiliations
1
Medical Oncology Clinic, Oncology Institute of Southern Switzerland, 6500 Bellinzona, Switzerland. Electronic address: marco.cefali@eoc.ch.
2
Medical Oncology Clinic, Oncology Institute of Southern Switzerland, 6500 Bellinzona, Switzerland.
PMID:
31677993
DOI:
10.1016/j.intimp.2019.105982
No abstract available
MeSH terms
Adult
Aged
Aged, 80 and over
Female
Humans
Inflammation / immunology
Leukocyte Count*
Lymphocyte Count*
Male
Middle Aged
Neoplasms / immunology
Neoplasms / mortality*
Retrospective Studies